In addition, the positive rate of F. nucleatum in the tumor tissues of responders (100%) is higher than non-responders (47%) (Fig. 1c), suggesting F. nucleatum in CRC tissues may be related to the therapeutic effect of PD-1/PD-L1 blockade. The gene discussed is PDCD1; the disease is colorectal carcinoma.